Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data will be presented at the 2025 American Society of Nephrology Kidney Week, taking place from November 6 to 9 in Houston, Texas. https://mma.prnewswire.com/media/2810526/Asahi_Kasei_Corporation_Calliditas_Therapeutics_Logo.jpg The presentations will include new secondary analyses from the Phase 3 NefIgArd study of Nefecon (marketed as TARPEYO® [budesonide] delayed-release […]

(NYSE MKT:CMT), 2025 Full Year Sales Guidance Down 10% to 12% from Prior Year, and Well-Positioned to Accelerate 2026 New Program Launches COLUMBUS, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in

(NasdaqGM:ENPH), FREMONT, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that its IQ(R) Battery systems are now eligible for San Diego Community Power's (Community Power) Solar Battery Savings program. Community Power is a

(NASDAQ:ARQT), ZORYVE foam 0.3% was safe, well-tolerated, and demonstrated durable and continuously improving efficacy in the treatment of seborrheic dermatitis up to 52 weeks Once-daily ZORYVE foam 0.3% is approved to treat seborrheic dermatitis in adults and adolescents 9 years of age and older WESTLAKE VILLAGE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics,

(NASDAQ:SABS),(NASDAQ:SABSW), MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) — SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its lead program in clinical development for delaying the progression of type 1 diabetes (T1D) in new onset Stage 3 patients, today announced that members of its management team

WHITE PLAINS, N.Y., Nov. 04, 2025 (GLOBE NEWSWIRE) — Romano Law Group, one of Florida's leading personal injury and trial firms, has entered into a strategic partnership with Anytime AI, a pioneering legal technology company transforming how law firms manage, draft, and accelerate their caseloads through artificial intelligence. This partnership marks a major step in

(NASDAQ:STKH), Existing Steakholder Shareholders Retain Majority Stake; Twine Shareholders Previously Invested in Steakholder and Provided Convertible Loan Since Converted into Equity, Both at a Substantial Premium Strategic Acquisition To Position the Combined Company As A Digital Printing Pioneering Force Geared Towards Global Trends Of Smart Manufacturing and Supply Chain Optimization Since its foundation, Twine has

(NASDAQ:SWAG),(NASDAQ:SWAGW),(Boerse Frankfurt – Freiverkehr:S9H), Quincy, MA, Nov. 04, 2025 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that it will host a conference call at 10:00 A.M. Eastern Time on Thursday,

(NASDAQ:RDVT), BOCA RATON, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the Southwest IDEAS Investor Conference being held November 19-20, 2025 in Dallas. Camilo Ramirez, Senior Vice President, Finance and Investor Relations, will present and host investor

(NASDAQ:AKBA), CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate in two investor conferences in